376 related articles for article (PubMed ID: 24625557)
21. Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid.
De Luca MA; Bimpisidis Z; Melis M; Marti M; Caboni P; Valentini V; Margiani G; Pintori N; Polis I; Marsicano G; Parsons LH; Di Chiara G
Neuropharmacology; 2015 Dec; 99():705-14. PubMed ID: 26327678
[TBL] [Abstract][Full Text] [Related]
22. Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats.
Schindler CW; Gramling BR; Justinova Z; Thorndike EB; Baumann MH
Drug Alcohol Depend; 2017 Oct; 179():387-394. PubMed ID: 28846955
[TBL] [Abstract][Full Text] [Related]
23. An assessment of concurrent cannabidiol and Δ⁹-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning.
Hempel BJ; Clasen MM; Nelson KH; Woloshchuk CJ; Riley AL
Exp Clin Psychopharmacol; 2018 Apr; 26(2):205-213. PubMed ID: 29648861
[TBL] [Abstract][Full Text] [Related]
24. Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence.
Barbieri M; Ossato A; Canazza I; Trapella C; Borelli AC; Beggiato S; Rimondo C; Serpelloni G; Ferraro L; Marti M
Neuropharmacology; 2016 Oct; 109():254-269. PubMed ID: 27346209
[TBL] [Abstract][Full Text] [Related]
25. [INCREMENT]9-Tetrahydrocannabinol discriminative stimulus effects of AM2201 and related aminoalkylindole analogs in rats.
Järbe TU; Gifford RS; Zvonok A; Makriyannis A
Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):211-4. PubMed ID: 26397760
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid receptors and reward in the rat: a conditioned place preference study.
Cheer JF; Kendall DA; Marsden CA
Psychopharmacology (Berl); 2000 Jul; 151(1):25-30. PubMed ID: 10958113
[TBL] [Abstract][Full Text] [Related]
27. CB1 receptor-mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH-081, a new component of spice/K2 preparations.
Basavarajappa BS; Subbanna S
Hippocampus; 2014 Feb; 24(2):178-88. PubMed ID: 24123667
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice.
Wiley JL; Lefever TW; Marusich JA; Grabenauer M; Moore KN; Huffman JW; Thomas BF
Neuropharmacology; 2016 Nov; 110(Pt A):143-153. PubMed ID: 27449567
[TBL] [Abstract][Full Text] [Related]
29. Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates.
Cooper ZD; Evans SM; Foltin RW
Exp Clin Psychopharmacol; 2021 Apr; 29(2):137-146. PubMed ID: 34043398
[TBL] [Abstract][Full Text] [Related]
30. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.
Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M
Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232
[TBL] [Abstract][Full Text] [Related]
31. Synthetic cannabinoids JWH-018, JWH-122, UR-144 and the phytocannabinoid THC activate apoptosis in placental cells.
Almada M; Alves P; Fonseca BM; Carvalho F; Queirós CR; Gaspar H; Amaral C; Teixeira NA; Correia-da-Silva G
Toxicol Lett; 2020 Feb; 319():129-137. PubMed ID: 31730886
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018.
Su MK; Seely KA; Moran JH; Hoffman RS
Clin Pharmacol Ther; 2015 Jun; 97(6):562-4. PubMed ID: 25788107
[TBL] [Abstract][Full Text] [Related]
33. Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.
Sañudo-Peña MC; Tsou K; Delay ER; Hohman AG; Force M; Walker JM
Neurosci Lett; 1997 Feb; 223(2):125-8. PubMed ID: 9089689
[TBL] [Abstract][Full Text] [Related]
34. The synthetic cannabinoid JWH-018 modulates Saccharomyces cerevisiae energetic metabolism.
Ferreira C; Couceiro J; Família C; Jardim C; Antas P; Santos CN; Outeiro TF; Tenreiro S; Quintas A
FEMS Yeast Res; 2019 Aug; 19(5):. PubMed ID: 31329229
[TBL] [Abstract][Full Text] [Related]
35. JWH-018 impairs sensorimotor functions in mice.
Ossato A; Vigolo A; Trapella C; Seri C; Rimondo C; Serpelloni G; Marti M
Neuroscience; 2015 Aug; 300():174-88. PubMed ID: 25987201
[TBL] [Abstract][Full Text] [Related]
36. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
Dhawan K; Kumar S; Sharma A
J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
[TBL] [Abstract][Full Text] [Related]
37. 1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice.
Wiley JL; Marusich JA; Martin BR; Huffman JW
Drug Alcohol Depend; 2012 Jun; 123(1-3):148-53. PubMed ID: 22127210
[TBL] [Abstract][Full Text] [Related]
38. Natural (∆
Malyshevskaya O; Aritake K; Kaushik MK; Uchiyama N; Cherasse Y; Kikura-Hanajiri R; Urade Y
Sci Rep; 2017 Sep; 7(1):10516. PubMed ID: 28874764
[TBL] [Abstract][Full Text] [Related]
39. Effect of delta9-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test.
Jarrett MM; Scantlebury J; Parker LA
Physiol Behav; 2007 Feb; 90(2-3):425-30. PubMed ID: 17118412
[TBL] [Abstract][Full Text] [Related]
40. Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.
Rajasekaran M; Brents LK; Franks LN; Moran JH; Prather PL
Toxicol Appl Pharmacol; 2013 Jun; 269(2):100-8. PubMed ID: 23537664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
